|
|
Volumn 39, Issue 6, 1990, Pages 603-605
|
|
Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans
a
|
|
Author keywords
Alzheimer's disease; cholinesterase inhibition; Galanthamine; pharmacokinetics; side effects; stereoselectivity
|
|
Indexed keywords
DRUG METABOLITE;
EPIGALANTHAMINE;
GALANTAMINE;
GALANTAMINONE;
UNCLASSIFIED DRUG;
CHOLINESTERASE INHIBITOR;
DRUG DERIVATIVE;
ADULT;
AGED;
ALZHEIMER DISEASE;
ARTICLE;
CHOLINESTERASE INHIBITION;
CLINICAL ARTICLE;
ERYTHROCYTE;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN EXPERIMENT;
MALE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
STEREOSPECIFICITY;
STRUCTURE ACTIVITY RELATION;
AGING;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG TOLERANCE;
ENZYMOLOGY;
METABOLISM;
STEREOISOMERISM;
ADMINISTRATION, ORAL;
AGED;
AGED, 80 AND OVER;
AGING;
ALZHEIMER DISEASE;
CHOLINESTERASE INHIBITORS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG TOLERANCE;
FEMALE;
GALANTHAMINE;
HUMAN;
MALE;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 0025572193
PISSN: 00316970
EISSN: 14321041
Source Type: Journal
DOI: 10.1007/BF00316106 Document Type: Article |
|
Times cited : (58)
|
|
References (10)
|
